Electroconvulsive therapy - Theoretical and practical clinical guide;Die elektrokrampftherapie: Theorie und praxis

Neuropsychiatrie

Volumn 18, Issue 1, 2004, Pages 1-17

  Conca, A ^a,f   Hinterhuber, H ^a   Prapotnik, M ^a   Geretsegger, C ^c   Frey, R ^a   Hausmann, A ^a   Hofmann, P ^a   Kasper, S ^a   Lahousen, T ^a   Konig P ^a   DiPauli, J ^a   Pramsohler, B ^e   Rittmansberger, H ^a   Wagner, W ^d   Pycha, R ^b  

^a LKH Rankweil ^*  (United States)

^b LKH Bruneck   (Italy)

^c Christian Doppler Klinik   (Austria)

^d GENERAL HOSPITAL KLAGENFURT   (Austria)

^e Privatklinik Villach   (Austria)

^f Abteilung Psychiatrie I   (Austria)

Author keywords

Consensus; Consent form; Electroconvulsive therapy; Indication; Mechanisms of action; Physical principles; Practical administration; Side effects

Indexed keywords

ANTIDEPRESSANT AGENT; ATROPINE; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHLORPROMAZINE; CLOZAPINE; FLUMAZENIL; FLUOXETINE; GLYCOPYRRONIUM BROMIDE; LITHIUM; NEUROLEPTIC AGENT; PAROXETINE;

ANESTHESIA; APNEA; ASPIRATION PNEUMONIA; AUSTRIA; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CATATONIA; CONSENSUS; DEPRESSION; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAPHY; HEART INFARCTION; HUMAN; INFORMED CONSENT; MANIA; MEDICAL SOCIETY; MEMORY DISORDER; MORTALITY; NEUROBIOLOGY; PHEOCHROMOCYTOMA; PREGNANCY; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

EID: 10844296440     PISSN: 09486259     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (167)

1. Cerletti U., L. Bini: Un nuovo metodo di shockterapia "l'elettro shock". Boll. Accad. Med. Roma 64, 136-138 (1938).
2. Hofmann P., G. Wieselmann, G. Herzog, H. G. Zapotoczky: Elektrokonvulsions-therapie (EKT) in Österreich. Eine Umfrage. Neuropsychiatrie 7, 204-206 (1993).
3. Janicak P. G., J.M. Davis, R.D. Gibbons, S. Ericksen, S. Chang, P. Gallagher: Efficacy of ECT: a meta-analysis. Am. J. Psychiatry 142, 297-302 (1985).
4. Prudic J., R.F. Haskett, B. Mulsant, K.M. Malone, H.M. Pettinati, S. Stephens, R. Greenberg, S.L. Rifas, H.A. Sackeim: Resistance to antidepressant medications and short-term clinical response to ECT. Am. J. Psychiatry 153, 985-992 (1996).
5. Petrides G., M. Fink, M.M. Husain, R. G. Knapp, A.J. Rush, M. Mueller, T.A. Rummans, K.M. O'Connor, K.G. Rasmussen Jr., H.H. Bernstein, M. Biggs, S.H. Bailine, C.H. Kellner: ECT remission rates in psychotic versus non-psychotic depressed patients: a report from CORE. J. ECT 17, 244-253 (2001).
6. The UK ECT Review Group: Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 8, 799-808 (2003).
7. Kho K.H., M.F. van Vreeswijk, S. Simpson, A.H. Zwinderman: A metaanalysis of electroconvulsive therapy efficacy in depression. J. ECT 19, 139-147 (2003).
8. Kroessler D.: Relative efficacy rates for therapies of delusional depression. Convuls. Ther. 1, 173-182 (1985).
9. Parker G., K. Roy, D. Hadzi-Pavlovic, F. Pedic: Psychotic (delusional) depression: a meta-analysis of physical treatments. J. Aff. Dis. 24, 17-24 (1992).
10. Mulsant B., R. Haskett, C. Prudic, M. Thase, K. Malone, J. Mann, H. Pettinati, H. Sackeim: Low use of neuroleptic drugs in treatment of psychotic major depression. Am. J. Psychiatry 154, 559-561 (1997).
11. Joffe R.T., C.H. Kellner: The role of ECT in refrectory depression. Convuls. Ther. 11, 77-79 (1995).
12. Sackeim H.A., D.P. Devanand, M.S. Nobler: Electroconvulsive Therapy. In: Floyd E., J. Bloom, D. Kupfer: Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York 1995, 1123-1141.
13. Tew J.D. Jr., B.H. Mulsant, R.F. Haskett, J. Prudic, M.E. Thase, R.R. Crowe, D. Dolata, A.E. Begley, C.F. Reynolds, H.A. Sackeim: Acute efficacy of ECT in the treatment of major depression in the old-old. Am. J. Psychiatry 156, 1865-1870 (1999).
14. Folkerts H.: Elektrokrampftherapie. Dtsch. Ärztebl. 92, A358-364 (1995).
15. American Psychiatric Association: The practice of ECT: recommendations for treatment, training and privileging (2nd edition). American Psychiatric Press, Washington, DC, 2001.
16. Dinan T.G., S. Barry: A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders. Acta Psychiatr. Scand. 80, 97-100 (1989).
17. Frey R., D. Schreinzer, A. Heiden, S. Kasper: Einsatz der Elektrokrampftherapie in der Psychiatrie. Nervenarzt 72, 661-676 (2001).
18. Häfner H., S. Kasper: Akute lebensbedrohliche Katatonie. Nervenarzt 53, 385-394 (1982).
19. Mann S.C., S.N. Caroff, H.R. Bleier: Lethal catatonia. Am. J. Psychiatry 143, 1374-1381 (1986).
20. Geretsegger C., E. Rochowanski: Electroconvulsive therapy in acute life-threatening catatonia with associated cardiac and respiratory decompensation. Convuls. Ther. 3, 291-295 (1987).
21. Bush G., M. Fink, G. Petrides, F. Dowling, A. Francis: Catatonia. II: Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr. Scand. 93, 137-143 (1996).
22. Malur C., A. Francis: Emergence of catatonia during ECT. J. ECT 17, 201-4 (2001).
23. Keck P.E. Jr., S.N. Caroff, S.L. McElroy: Neuroleptic malignant syndrome and malignant hyperthermia: end of a controversy? J. Neuropsychiatry Clin. Neurosci. 7, 135-144 (1995).
24. Fink M.: Catatonia: syndrome or schizophrenia subtype? Recognition and treatment. J. Neural. Transm. 108, 637-644 (2001).
25. Krueger R.B., H.A. Sackeim: Electroconvulsive therapy and schizophrenia. In: Hirsch S.R., D.R. Weinberger (eds): Schizophrenia. Blackwell, Oxford, 503-545 (1996).
26. Freemann C.P.: The ECT Handbook: The second report of the Royal College of Psychiatrists' Special committee on ECT. Council Report: CR39. Henry Ling, Dorset Press, Dorchester 1995.
27. Childers R.: Comparison of four regimens in newly admitted female schizophrenics. Am. J. Psychiatry 120, 1010-1011 (1964).
28. Conley R.R., D.L. Kelly: Management of treatment resistant schizophrenia. Biol. Psychiatry 50, 898-911 (2001).
29. Chanpattana W., M.L. Chakrabhand, R. Kongsakon, P. Techakasem, W. Buppanharun: Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia. J. ECT 15, 129-139 (1999).
30. Klapheke M.M.: Clozapine, ECT and schizoaffective disorder, bipolar type. Convuls. Ther. 7, 36-39 (1991).
31. Mukherjee S.: Combined ECT and lithium therapy. Convuls. Ther. 9, 274-284 (1993).
32. Swoboda E., A. Conca, P. König, R. Waanders, M. Hansen: Maintenance ECT in affective and schizoaffektive disorder. Neuropsychobiology 43, 23-28 (2001).
33. Small J.G., M.H. Klapper, J.J. Kellams, M.J. Miller, V. Milstein, P.H. Sharpley, I.F. Small: Electroconvulsive treatment compared with lithium in the management of manic states. Arch. Gen. Psychiatry 45, 727-732 (1988).
34. Mukherjee S., H.A. Sackeim, D.B. Schnur: Electroconvulsive therapy of acute manic episodes: a review of 50-year experience. Am. J. Psychiatry 151, 169-176 (1994).
35. Sikdar S., P. Kulhara, A. Avasthi, H. Singh: Combined chlorpromazine and the electroconvulsive therapy in mania. Br. J. Psychiatry 164, 207-223 (1994).
36. Zwil A.S., T.W. McAllister, T.R. Price: Safety and efficacy of ECT in depressed patients with organic brain disease: review of a clinical experience. Convuls. Ther. 8, 103-109 (1992).
37. Van Waarde J.A., J.J. Stolker, R.C. Van der Mast: ECT in mental retardation: a review. J. ECT 17, 236-243 (2001).
38. Mac D.S., M.P. Pardo: Systemic lupus erythematosus and catatonia: a case report. J. Clin. Psychiatry 44, 155-156 (1983).
39. Hafeiz H.B.: Psychiatric manifestations of enteric fever. Acta Psychiatr. Scand. 75, 69-73 (1987).
40. Dinwiddie S.H., W.C. Drevets, D.R. Smith: Treatment of phencyclidine-associated psychosis with ECT. Convuls. Ther. 4, 230-235 (1988).
41. Lohmann T., K. Nishimura, O. Sabri, J. Klosterkötter: Erfolgreiche Elektrokrampftherapie bei Cotard-Syndrom mit bitemporaler Minderperfusion. Nervenarzt 67, 400-403 (1996).
42. Strömgren L.S.: ECT in acute delirium and related clinical states. Convuls. Ther. 13, 10-17 (1997).
43. Balldin J., A.K. Granerus, G. Lindstedt, K. Modigh, J. Walinder: Predictors for improvement after electroconvulsive therapy in parkinsonian patients with on-off symptoms. J. Neural. Transm. 52, 199-211 (1981).
44. Andersen K., J. Balldin, C.G. Gottfries, A.K. Granerus, K. Modigh, L. Svennerholm, A. Wallin: A double-blind evaluation of electroconvulsive therapy in Parkinson disease with "on-off" phenomena. Acta Neurol. Scand. 76, 191-199 (1987).
45. Faber R., M.R. Trimble: Electroconvulsive therapy in Parkinson's disease and other movement disorders. Mov. Disord. 6, 293-303 (1991).
46. Zwil A.S., R.J. Plechat: ECT in the treatment of patients with neurological and somatic disease. Int. J. Psychiatry 24, 1-29 (1994).
47. Kramer B.A.: Naturalistic review of maintenance ECT at a university setting. J. ECT 15, 262-269 (1999).
48. Sachdev P., C. Mason, D. Hadzi-Pavlovic: Case-control study of neuroleptic malignant syndrome. Am. J. Psychiatry 154, 1156-1158 (1997).
49. Nisijima K., T. Ishiguro: Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases. J. ECT 15, 158-163 (1999).
50. Trollor J.N., P.S. Sachdev: Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases. Aust. N.Z. J. Psychiatry 33, 650-659 (1999).
51. Sackeim H.A.: The anticonvulsant hypothesis of the mechanisms of action of ECT: current status. J. ECT 15. 5-26 (1999).
52. Lisanby S.H., C.W. Bazil, S.R. Resor, M.S. Nobler, D.A. Finck, H.A. Sackeim: ECT in the treatment of status epilepticus. J. ECT 17, 210-215 (2001).
53. Postolache T.T., J.H. Londono, R.G. Halem, M.D. Newmark: Electroconvulsive therapy in tardive dystonia. Convuls. Ther. 11, 275-279 (1995).
54. Yassa R., H. Hoffmann, M. Canakis: The effect of electroconvulsive therapy on tardive dyskinesia: a prospective study. Convuls. Ther. 6, 194-198 (1990).
55. Liberzon I., J.R. DeQuardo, G. Sidell, C. Mazzara, R. Tandon: Post-ECT dyskinesia. Convuls. Ther. 7, 40-44 (1991).
56. Squire L.R., P.C. Slater, P.L. Miller: Retrograde amnesia and bilateral electroconvulsive therapy: long-term follow-up. Arch. Gen. Psychiatry 38, 89-95 (1981).
57. Frith C.D., M. Stevens, E.C. Johnstone, J.F. Deakin, P. Lawler, T.J. Crow: Effects of ECT and depression on various aspects of memory. Br. J. Psychiatry 142, 1-8 (1983).
58. Lisanby S.H., J.H. Maddox, J. Prudic, D.p. Devanand, H.A. Sackeim: The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch. Gen. Psychiatry 57, 581-590 (2000).
59. Coleman E.A., H.A. Sackeim, J. Prudic, D.p. Devanand, M.C. McElhiney, B.J. Moody: Subjective memory complaints before and after electroconvulsive therapy. Biol. Psychiatry 39, 436-356 (1996).
60. Sackeim H.A., Y. Stern: The neuropsychiatry of memory and amnesia. In: Yudofsky S.C., R.E. Hales: The American Psychiatric Press Textbook of Neuropsychiatry. American Psychiatric Press, Washington DC, 1997, 501-518.
61. Hasse-Sander I., H. Müller, W. Schurig, S. Kasper, H.J. Möller: Auswirkungen der Elektrokrampftherapie auf die kognitiven Funktionen bei therapieresistenten Depressionen. Nervenarzt 69, 609-616 (1998).
62. Jones B.P., M. Henderson, C.A. Welch: Executive functions in unipolar depression before and after electroconvulsive therapy. Int. J. Neurosci. 38, 287-297 (1988).
63. Abrams R.: Electroconvulsive Therapy (3rd edition). Oxford University Press, New York 1997.
64. Weiner R.D., H.J. Rogers, J.R. Davidson, E.M. Kahn: Effects of electroconvulsive therapy upon brain electrical activity. Ann. N.Y. Acad. Sci. 462, 270-281 (1986a).
65. Weiner R.D., H.J. Rogers, J.R. Davidson, L.R. Squire: Effects of stimulus parameters on cognitive side effects. Ann. N.Y. Acad. Sci. 462, 315-325 (1986b).
66. Nadel L., M. Moscovitch: Memory consolidation, retrograde amnesia and the hippocampal complex. Curr. Opin. Neurol. 7, 217-227 (1997).
67. Korin H., M. Fink, S. Kwalwasser: Relation of changes in memory and learning to improvement in electroshock. Confinia Neurologica 16, 83-96 (1956).
68. Sobin C., H.A. Sackeim, J. Prudic, D.P. Devenand, B.J. Moody, M.C. Mc Elhiney: Predictors of retrograde amnesia following ECT. Am. J. Psychiatry 152, 995-1001 (1995).
69. Squire L.R.: Memory functions as affected by electroconvulsive therapy. Ann. N.Y. Acad. Sci. 46, 307-314 (1986).
70. Sackeim H.A., J. Prudic, D.P. Devanand, J.E. Kiersky, L. Fitzsimons, B.J. Moody, M.C. McElhiney, E.A. Coleman, J.M. Settembrino: Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N. Engl. J. Med. 328, 839-1326 (1993).
71. Damasio A.R., B.J. Eslinger, H. Damasio, G.W. Van Hoesen, S. Cornell: Multimodal amnesic syndrome following bilateral temporal and basal forebrain damage. Arch. Neurol. 42, 252-259 (1985).
72. McCall M.V., D.M. Reboussin, R.D. Weiner, H.A. Sockeim: Titrated moderately suprathreshold vs. fixed high dose right unilateral electroconvulsive therapy. Arch. Gen. Psychiatry 57, 438-444 (2000).
73. Kellner C.H.: The cognitive effects of ECT: bridging the gap between research and clinical practice. Convuls. Ther. 12, 133-135 (1996).
74. Kellner C.H., W.V. McCall: Novel electrode placements: time to reassess. J. ECT 15, 115-117 (1999).
75. Sackeim H.A.: The cognitive effects of electroconvulsive therapy. In: Moos W.H., E.R. Gamzu, L.J. Thal: Cognitive disorders: pathophysiology and treatment. Marcel Dekker, New York, 183-228 (1992a).
76. Sackeim H.A., J. Freeman, M. Mc Elhiney, E. Coleman, J. Prudic, D.P. Devanad: Effects of major depression on estimates intelligence. J. Clin. Exp. Neuropsychol. 14, 268-288 (1992b).
77. Sackeim H.A.: Antidepressant properties of ECT and TMS: Modulation of prefrontal cortex function. Int. J. Neuropsychopharmacol. 3, 27 (2000).
78. Devanand D.P., H.A. Sackeim, P. Decina, J. Prudic: The development of mania and organic euphoria during ECT. J. Clin. Psychiatry 49, 69-71 (1988).
79. Miller A.R., K.E. Isenberg: Reversible ischemic neurologic deficit after ECT. Case report. J. ECT 14, 42-48 (1998).
80. Abrams R.: The mortality rate with ECT. Convuls. Ther. 13, 125-127 (1997).
81. Beinlich I.: Anaesthesia-related morbidity and mortality. Anästhesiol. Intensivmed. Notfallmed. Schmerzther. 26, 177-185 (1991).
82. McCall W.V., S. Reid, M. Ford: Electrocardiographic and cardiovascular effects of subconvulsive stimulation during titrated right unilateral ECT. Convuls. Ther. 10, 25-33 (1994).
83. Maltbie A.A., M.S. Wingfield, M.R. Volow, R.D. Weiner, J.L. Sullivan, J.O. Cavenar Jr.: Electroconvulsive therapy in the presence of brain tumor: case reports and an evaluation risk. J. Nerv. Ment. Dis. 168, 400-405 (1980).
84. Applegate R.J.: Diagnosis and management of ischemic heart disease in the patient scheduled to undergo electroconvulsive therapy. Convuls. Ther. 13, 128-144 (1997).
85. Hunt S.A., E. Kaplan: ECT in the presence of a cerebral aneurysm. J. ECT 14, 123-4 (1998).
86. Schneekloth T.D., T.A. Rummans, K.M. Logan: Electroconvulsive therapy in adolescents. Convuls. Ther. 9, 158-166 (1993).
87. Ferill M.J., W.A. Kehoe, J.J. Jacisin: ECT during pregnancy: physiologic and pharmacologic considerations. Convuls. Ther. 8, 186-200 (1992).
88. Miller L.J.: Use of electroconvulsive therapy during pregnancy. Hosp. Commun. Psychiatry 45, 444-450 (1994).
89. Devanand D.P., A.J. Dwork, E.R. Hutchinson, T.G. Bolwig, H.A. Sackeim: Does ECT alter brain structure? Am. J. Psychiatry 151, 957-970 (1994).
90. Alexander L., H. Löwenbach: Experimental studies on electroshock treatment: the intracerebral vascular reaction as an indicator of the path of the current and the threshold of early changes within the brain tissue. J. Neuropathol. Exp. Neurol. 3, 139-171 (1944).
91. Agnew W.F., D.B. McCreery: Considerations for safety in the use of extracranial stimulation for motor-evoked potentials. Neurosurgery 20, 143-147 (1987).
92. Weaver L.A., R. W. Williams: The electroconvulsive therapy stimulus. In: Abrams R., W.B. Essman: Electroconvulsive Therapy: biological foundations and clinical applications. Spectrum Publications, New York 1982, 129-156.
93. Scott A.I., R.H. Douglas, A. Whitfield, R.E. Kendell: Time course of cerebral magnetic resonance imaging study of ECT-treated depressed patients. Biol. Psychiatry 27, 102-104 (1990).
94. Laursen H., A. Gjerris, T.G. Bolwig, D.I. Barry: Cerebral edema and vascular permeability to serum proteins following electroconvulsive shock in rats. Convuls. Ther. 7, 237-244 (1991).
95. Bergsholm P., J.L. Larsen, K. Rosendahl, F. Holsten: Electroconvulsive therapy and cerebral computed tomography: a prospective study. Acta Psychiatr. Scand. 80, 566-572 (1989).
96. Coffey C.E., W.E. Wilkinson, R.D. Weiner, I.A. Parashos, W.T. Djang, M.C. Webb, G.S. Figiel, C.E. Spritzer: Quantitative cerebral anatomy in depression: a controlled magnetic resonance imaging study. Arch. Gen. Psychiatry 50, 7-16 (1993).
97. Puri B.K., A. Oatridge, N. Saeed, J.E. Ging, H.M. McKee, S.K. Lekh, J.V. Hajnal: Does electroconvulsive therapy lead to changes in cerebral structure? Br. J. Psychiatry 173, 267-272 (1998).
98. Felber S.R., R. Pycha, M. Hummer, F.T. Aichner, W.W. Fleischhacker: Localized proton and phosphorus magnetic resonance spectroscopy following electroconvulsive therapy. Biol. Psychiatry 33, 651-654 (1993).
99. Ende G., D.F. Braus, S. Walter, W. Weber-Fahr, F.A. Henn: The hippocampus in patients treated with electroconvulsive thearpy: a proton magnetic resonance spectroscopic imaging study. Arch. Gen. Psychiatry 57, 937-943 (2000).
100. Obergriesser T., G. Ende, D.F. Braus, F.A. Henn: Long-term follow-up of magnetic resonance-detectable choline signal changes in the hippocampus of patients treated with electroconvulsive therapy. J. Clin. Psychiatry 64, 775-80 (2003)
101. Conca A., A. Prapotnik, W. Peschina, P. König: Simultaneous pattern of rCBF and rCMRGlu in continuation ECT. Case reports. Psychiatry Res. Neuroimag. in Druck (2003).
102. Heyck H.: Über einen Himbefund ohne Ganglienzellausfälle nach 355 Elektrokrampfbehandlungen. Monatsschr. Psychiatrie Neurologie 129, 128-137 (1955).
103. Lippman S., M. Manshadi, M. Wehry, R. Byrd, W. Past, W. Keller, J. Schuster, S. Elam, D. Meyer, R. O'Daniel: 1,250 electroconvulsive treatments without evidence of brain injury. Br. J. Psychiatry 147, 203-204 (1985).
104. Holmes G.L.: Do seizures cause brain damage? Epilepsia 32, S14-28 (1991).
105. Lado F.A., E.C. Laureta, S.L. Moshe: Seizure-induced hippocampal damage in the mature and immature brain. Epilept. Disord. 4, 83-97 (2002).
106. Fetterman J.L.: Electrocoma therapy of psychoses. Ann. Intern. Med. 17, 775-789 (1942).
107. Windle W.F., W.J. Krieg, A.J. Arieff: Failure to detect structural changes in the brain after electrical shock. Quarterly Bull. Northwest University Med. School 19, 181-188 (1945).
108. Wasterlain C.G., F. Plum: Vulnerability of developing rat brain to electroconvulsive seizures. Arch. Neurol. 29, 38-45 (1973).
109. Sackeim H.A., J. Long, B. Luber, J.R. Moeller, I. Prohovnik, D.P. Devanand, M.S. Nobler: Physical properties and quantification of ECT stimulus: I. Basic principles. Convuls. Ther. 10, 93-123 (1994).
110. Swartz C.M.: Beyond the seizure duration as a measure of treatment quality. Convuls. Ther. 9, 1-7 (1993).
111. Sackeim H.A., J. Prudic, D.P. Devanand, M.S. Nobler: S.H. Lisnaby, S. Peyser, L. Fitzsimons, B.J. Moody, J. Clark: A prospective, randomised, double-blind comparison of bilateral and right unilateral ECT at different stimulus intensities. Arch. Gen. Psychiatry 57, 425-434 (2000).
112. Swartz C.M.: Repeated ECT Stimuli and the Seizure Threshold. Convuls. Ther. 6, 181-187 (1990).
113. Coffey C.E., J. Lucke, R.D. Weiner, A.D. Krystal, M. Aque: Seizure threshold in electroconvulsive therapy (ECT): I. Initial seizure threshold. Biol. Psychiatry 37, 1183-1720 (1995a).
114. Coffey C.E., J. Lucke, R.D. Weiner, A.D. Krystal, M. Aque: Seizure threshold in electroconvulsive therapy (ECT) II. The anticonvulsant effect of ECT. Biol. Psychiatry 37, 777-788 (1995b).
115. Kellner C.H.: Seizure interference by medications: how big a problem? Convuls. Ther. 13, 1-3 (1997).
116. Geretsegger C., E. Rochowanski, C. Kartnig, A.F. Unterrainer: Propofol and methohexital as anesthetic agents for electroconvulsive therapy (ECT): a comparison of seizure-quality measures and vital signs. J. ECT 14, 28-35 (1998).
117. Conca A., R. Germann, P. König: Etomidate vs thiopentone in electroconvulsive therapy. An interdisciplinary challenge for anaesthesiology and psychiatry. Pharmacopsychiatry 36, 94-97 (2003).
118. Gaebel W., P. Falkai: Entwurf von DGPPN-Leitlinien zur Indikation und Dumhführung der Elektrokrampftherapie (EKT). Nervenarzt 67, 509-514 (1996).
119. Weiner R.D.: Stimulus dosing in ECT: the debate. Stimulus dosing with ECT: To titrate or not to titrate - that is the question. Convuls. Ther. 13, 7-9 (1997).
120. Fink M.: Stimulus dosing in ECT: the debate. Energy dosing in ECT: threshold stimulation or formula? Convuls. Ther. 13, 4-6 (1997).
121. Pettinati H.M., K.S. Mathisen, J. Rosenberg, J.F. Lynch: Meta-analytical approach to reconciling discrepancies in efficacy between bilateral and unilateral electroconvulsive therapy. Convuls. Ther. 2, 7-17 (1986).
122. Gujavarty K., L.B. Greenberg, M. Fink: Electroconvulsive therapy and neuroleptic medication in therapy-resistant positive symptom psychosis. Convuls. Ther. 11, 483-496 (1987).
123. Bailine S.H., A. Rifkin, E. Kayne, J.A. Selzer, J. Vital-Herne, M. Blieka, S. Pollack: Comparison of bifrontal and bitemporal ECT for major depression. Am. J. Psychiatry 157, 121-123 (2000).
124. Kellner C H.: Defining a course of ECT. Convuls. Ther. 11, 229-231 (1995).
125. Lerer B., B. Shapira, A. Calev, N. Tubi, H. Drexler, S. Kindler, D. Lidsky, J.E. Schwartz: Antidepressant and cognitive effects of twice vs. 3 times-weekly ECT. Am. J. Psychiatry 152, 564-570 (1995).
126. McAllister D.A., M.G. Perri, R.C. Jordan, F.P. Rauscher, A. Sattin: Effects of ECT given two vs. three times weekly. Psychiatry Res. 21, 63-69 (1987).
127. Andrade C., S. Kurinji: Continuation and maintenance ECT: a review of recent research. J. ECT 18, 149-152 (2002).
128. Willeit M., N. Praschak-Rieder, S. Kasper: Elektrokrampftherapie als Erhaltungstherapie und Rezidivprohylaxe bei psychiatrischen Störungen und Morbus Parkinson. Wien. Klin. Wochenschr. 115, 281-290 (2003).
129. Frankel F.H.: The 1978 and 1990 APA Task Force Reports. Convuls. Ther. 6, 79-81 (1990).
130. Chanpattana W., M.L. Chakrabhand: Factors influencing treatment frequency of continuation ECT in schizophrenia. J. ECT 17, 190-194 (2001).
131. Katschnigt H., H. Donat, W.W. Fleischhacker, U. Meise: 4 × 8 Empfehlungen zur Behandlung von Schizophrenie. edition pro mente, Linz 2000, 41-42.
132. Gagne G.G. Jr., M.J. Furman, L.L. Carpenter, L.H. Price: Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. Am. J. Psychiatry 157, 1960-1965 (2000).
133. Sackeim H.A., R.F. Haskett, B.H. Mulsant, M.E. Thase, J.J. Mann, H.M. Pettinati, R.M. Greenberg, R.R. Crowe, T.B. Cooper, J. Prudic: Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy. JAMA 285, 1299-1307 (2001).
134. Stern R.A., C.T. Nevels, M.E. Shelhorse, M.L. Prohaska, G.A. Mason, A.J. Prange Jr.: Antidepressant and memory effects of combined thyroid hormone treatment and electroconvulsive therapy: preliminary findings. Biol. Psychiatry 30, 623-627 (1991).
135. Krueger R.B., H.A. Sackeim, E.R. Gamzu: Pharmacological treatment of the cognitive side effects of ECT: a review. Psychopharmacol. Bull. 28, 409-424 (1992).
136. Chamberlin E., G.E. Tsai: A glutamatergic model of ECT-induced memory dysfunction. Harv. Rev. Psychiatry 5, 307-317 (1998).
137. Pettinati H.M., S.M. Stephens, K.M. Willis, S.E. Robin: Evidence for less improvement in depression in patients taking benzodiazepines during unilateral ECT. Am. J. Psychiatry 147, 1029-1035 (1990).
138. Krystal A.D., B.V. Watts, R.D. Weiner, S. Moore, D.C. Steffens, V. Lindahl: The use of flumazenil in the anxiuos and benzodiazepine dependent ECT patient. J. ECT 14, 5-14 (1998).
139. Kellner C.H., L.N. Bourgon: Combining ECT and antidepressants: time of reassess. J. ECT 14, 65-67 (1998).
140. Nelson J.P., L. Bejamin: Efficacy and safety of combined ECT tricyclic antidepressant therapy in the traetment of depressed geriatric patients. Convuls. Ther. 5, 321-329 (1989).
141. Freeman C.P., R.E. Kendell: ECT, 1: patients' experiences and attitudes. Br. J. Psychiatry 137, 8-16 (1980).
142. Lauritzen L., K. Odgaard, L. Clemmesen, M. Lunde, J. Öhrström, C. Black, P. Bech: Relapse prevention by mean of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr. Scand. 94, 241-251 (1996).
143. Pritchett J.T., H.J. Bernstein, C.H. Kellner: Combined ECT and antidepressant drug therapy. Convuls. Ther. 9, 256-261 (1993).
144. Curran S.: Effect of paroxetine on seizure length during electroconvulsive therapy. Acta Psychiatr. Scand. 92, 239-40 (1995).
145. Smith K., W.R. Surphlis, M.D. Gynther, A.M. Shimkunas: ECT chlorpromazine and chlorpromazine compared in the treatment of schizophrenia. J. Nerv. Ment. Dis. 144, 284-290 (1967).
146. Janowsky E.C., C. Risch, D.S. Janowsky: Effects of anesthesia on patients taking psychotropic drugs. J. Clin. Psychopharmacol. 1, 14-20 (1981).
147. Frankenburg F.R., T. Supps, P.E. McLean: Combined clozapine and electroconvulsive therapy. Convuls. Ther. 9, 176-180 (1993).
148. Klapheke M.M.: Combining ECT and Antipsychotic agents: benefits and risks. Convuls. Ther. 9, 241-255 (1993).
149. Cardwell B.A., B. Nakai: Seizure activity in combined clozapin and ECT: a retrospective view. Convuls. Ther. 11, 110-113 (1995).
150. Fink M.: ECT and clozapine in schizophrenia (Editorial). J. ECT 14, 223-226 (1998).
151. Masiar S.J., C.A. Johns: ECT following clozapine. Br. J. Psychiatry 158, 135-136 (1991).
152. Landy D.A.: Combined use of clozapine and electroconvulsive therapy. Convuls. Ther. 7, 218-221 (1991).
153. Small J. G., V. Milstein: Lithium interactions: lithium and electroconvulsive therapy. J. Clin. Psychopharmacol. 10, 346-350 (1990).
154. Coppen A., M.T. Abou-Saleh, P. Milln, J. Bailey, M. Metcalfe, B.H. Burns, A. Armond: Lithium continuation therapy following electroconvulsive therapy. Br. J. Psychiatry 139, 284-287 (1981).
155. Lippman S.B., C.A. Tao: Electroconvulsive therapy and lithium: safe and effective treatment. Convuls. Ther. 9, 54-57 (1993).
156. Taub E., S. Londstrom, V. Klem: A new injectable carbamacepine solution: antiepileptic effects and pharmacological properties. Epilepsia Res. 7, 59-64 (1990).
157. Zerateca J. jun., M. Tohen, G. Baraibar: Combined valproate or carbamacepine and electroconvulsive therapy. Ann. Clin. Psychiatry 3/9, 19-25 (1997).
158. Nutt D.J., P. Glue: The neurobiology of ECT. Animal studies. In: Coffey C.E.: The Clinical Science of Electroconvulsive Therapy. American Psychiatric Press, Washington, DC, 1993, 213-234.
159. Fochtmann L.J.: What do rodents and test tubes teach us about ECT? Convuls. Ther. 10, 287-297 (1994).
160. Nobler M., H.A. Sackeim, I. Prohovnik, J. Moeller, S. Mukherjee, D. Schnur, J. Prudic, D. Devanand: Regional cerebral blood flow in mood disorders, III: treatment and clinical response. Arch. Gen. Psychiatry 51, 884-1007 (1994).
161. Newman M.E., E. Gur, B. Shapira, B. Lerer: Neurochemical mechanisms of action of ECS: evidence from in vivo studies. J. ECT 14, 153-118 (1998).
162. Mann J.J.: Neurobiological correlates of the antidepressant action of electroconvulsive therapy. J. ECT 14, 172-180 (1998).
163. Mathé A.A.: Neuropeptides and electroconvulsive therapy. J. ECT 15, 60-75 (1999).
164. Stenfors C., P. Bjellerup, A.A. Mathé, E. Theodorsson: Concurrent analysis of neuropeptides and biogenic amines in brain tissue of rats treated with electroconvulsive stimuli. Brain Res. 698, 39-45 (1995).
165. Neubauer H.: Kriterien für die Beurteilung der Einwilligungsfä higkeit bei psychisch Kranken. Psychiatr. Prax. 20, 166-171 (1993).
166. Hopf G., G Aigner: Unterbringungsgesetz. Manz Verlag, Sonderausgabe Wien 1993, 82.
167. Radner A., A. Haslinger, P. Reinberg, T. Radner: Krankenanstaltenrecht. Rudolf Traum Verlag, Linz 2000, 55. Lieferung 2001.